15 Quotes by Andrea Gambotto

This is a very potent vaccine. It took roughly about 30 days to make the vaccine from when we received the sequence information from CDC in Atlanta.

Eventually we will need to partner with a company for large-scale production of vaccine.

That means there is a lot of chance of getting cross-reactivity.

It takes a little over a month for us to develop a recombinant vector vaccine compared to a minimum of several months via traditional methods. This capacity will be particularly invaluable if the virus begins to mutate rapidly, a phenomenon that often limits the ability of traditional vaccines to contain outbreaks of mutant strains.

In humans, the H5N1 bird flu takes about two weeks to kill, so there is time for T cells to come out and give protection.

And if avian flu develops into a pandemic human strain - as many experts fear it may - the vaccine might complement traditional vaccines and be used to protect people.